Defining biomaterial-driven design principles for bioabsorbable flow diverters: current state and perspectives
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. An analysis of the incidence and cost of intracranial aneurysm and subarachnoid haemorrhage treatment between 2013 and 202110.3390/ijerph20053828 ↗
2. Epidemiology and genetics of intracranial aneurysms10.1016/j.ejrad.2012.12.026 ↗
3. Cranial nerve palsies and intracranial aneurysms: a narrative review of patterns and outcomes10.25259/SNI_531_2024 ↗
4. EHMTI-0142. Features of the headache secondary to unruptured intracranial aneurysm with oculomotor nerve paresis
5. The mechanical characterization of blood vessels and their substitutes in the continuous quest for physiological-relevant performances. A critical review
6. Intracranial aneurysms: pathology, genetics, and molecular mechanisms10.1007/s12017-019-08537-7 ↗
7. A review of hemodynamic parameters in cerebral aneurysm10.1016/j.inat.2020.100716 ↗
8. Size, localization and risk factors in ruptured and unruptured brain aneurysms10.33425/2639-944X.1407 ↗
9. Blister-like aneurysms of middle cerebral artery: a multicenter retrospective review of diagnosis and treatment in three patients10.1007/s10143-014-0581-3 ↗
10. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial10.1053/jscd.2002.130390 ↗
11. Doubled stenting for effective occlusion of a dissecting carotid artery aneurysm10.1177/159101990000600411 ↗
12. Treatment of a ruptured dissecting vertebral artery aneurysm with double stent placement: case report
13. Mechanism of action and biology of flow diverters in the treatment of intracranial aneurysms10.1093/neuros/nyz324 ↗
14. Immediate clinical outcome of patients harboring unruptured intracranial aneurysms treated by endovascular approach: results of the ATENA study10.1161/STROKEAHA.107.512756 ↗
15. Intracranial aneurysms: review of current treatment options and outcomes
16. A review on biodegradable materials for cardiovascular stent application10.1007/s11706-016-0344-x ↗
17. Evolution of flow-diverter endothelialization and thrombus organization in giant fusiform aneurysms after flow diversion: a histopathologic study10.3174/ajnr.A4336 ↗
18. Endothelialization following flow diversion for intracranial aneurysms: a systematic review10.3174/ajnr.A5955 ↗
19. Computational flow diverter implantation—A comparative study on pre-interventional simulation and post-interventional device positioning for a novel blood flow modulator10.3390/fluids9030055 ↗
20. Intraluminal flow diverter design primer for neurointerventionalists10.3174/ajnr.A8076 ↗
21. Fatigue and life prediction for cobalt-chromium stents: a fracture mechanics analysis10.1016/j.biomaterials.2005.10.012 ↗
22. Pipeline embolization device in the treatment of recurrent previously stented cerebral aneurysms10.3174/ajnr.A4613 ↗
23. Flow diverter technology for the treatment of intracranial aneurysms: a review10.1115/1.4067627 ↗
24. The evolution of flow-diverting stents for cerebral aneurysms; historical review, modern application, complications, and future direction10.3340/jkns.2020.0034 ↗
25. Safety and effect of pipeline flex embolization device for complex unruptured intracranial aneurysms
26. Pipeline flex embolization device (Ped flex) for the treatment of intracranial aneurysms: periprocedural outcomes and first-year angiographic results
27. Pipeline embolization device and pipeline flex versus surpass streamline flow diversion in intracranial aneurysms: a retrospective propensity score–matched study10.1016/j.wneu.2022.02.025 ↗
28. Flow diverter braid deformation following treatment of cerebral aneurysms: incidence, clinical relevance, and potential risk factors
29. Non-ischemic cerebral enhancing (NICE) lesions after flow diversion for intracranial aneurysms: a multicenter study10.1136/jnis-2023-021176 ↗
30. Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification10.1136/neurintsurg-2016-012612 ↗
31. Flow-diverter devices in the treatment of intracranial aneurysms: a meta-analysis and systematic review10.1177/1971400915621321 ↗
32. Bilateral delayed non-ischemic enhancing brain lesions after treatment with flow-diverter10.1007/s10072-024-07378-y ↗
33. Bioresorbable poly (L-Lactic acid) flow diverter versus cobalt-chromium flow diverter: in vitro and in vivo analysis10.1161/STROKEAHA.122.042043 ↗
34. Magnesium-based bioresorbable flow diverter for intracranial aneurysms: a pilot study of biocompatibility and bioresorption in a rabbit vascular model
35. A review of current flow diverters10.5797/jnet.ra.2023-0078 ↗
36. Microstructured thin film nitinol for a neurovascular flow-diverter
37. First multicenter experience using the silk vista flow diverter in 60 consecutive intracranial aneurysms: technical aspects10.1136/neurintsurg-2021-017421 ↗
38. Silk® flow diverter device for intracranial aneurysm treatment: a systematic review and meta-analysis10.5469/neuroint.2021.00234 ↗
39. Silk + flow-diverter stent for the treatment of intracranial aneurysms associated with balloon angioplasty: a retrospective study10.25259/SNI_97_2023 ↗
40. Patient outcomes after treatment of brain aneurysm in small diameter vessels with the silk vista baby flow diverter: a systematic review10.1177/15910199221091645 ↗
41. The Silk Vista Baby: initial experience and report of two cases10.1177/1591019919839196 ↗
42. Pipeline for uncoilable or failed aneurysms: 3-year follow-up results10.3171/2015.6.JNS15311 ↗
43. Safety and efficacy of the p48 MW and p64 flow modulation devices: a systematic review and meta-analysis10.3171/2023.2.FOCUS22648 ↗
44. In-stent stenosis after p64 flow diverter treatment10.1007/s00062-017-0591-y ↗
45. Diversion-p64: results from an international, prospective, multicenter, single-arm post-market study to assess the safety and effectiveness of the p64 flow modulation device10.1136/neurintsurg-2021-017809 ↗
46. Surface-modified flow diverter p48-MW-HPC: preliminary clinical experience in 28 patients treated in two centers10.1016/j.neurad.2020.11.006 ↗
47. Radiopaque FeMnN-Mo composite drawn filled tubing wires for braided absorbable neurovascular devices
48. Flow diverter performance comparison of different wire materials for effective intracranial aneurysm treatment10.3390/bioengineering11010076 ↗
49. Acute treatment of ruptured fusiform posterior circulation posterior cerebral, superior cerebellar, and posterior inferior cerebellar artery aneurysms with fred flow diverter: report of 5 cases10.1093/ons/opy194 ↗
50. The Fred for cerebral aneurysms of the posterior circulation: a subgroup analysis of the EUFRED registry10.3174/ajnr.A6447 ↗
51. First United States multicenter experience with the new-generation FRED X surface-modified flow diversion stent: feasibility, safety, and short-term efficacy10.3171/2023.7.JNS23966 ↗
52. The FRED flow-diverter stent for intracranial aneurysms: clinical study to assess safety and efficacy10.3174/ajnr.A4251 ↗
53. European multicenter study for the evaluation of a dual-layer flow-diverting stent for treatment of wide-neck intracranial aneurysms: the European flow-redirection intraluminal device study10.3174/ajnr.A5592 ↗
54. The derivo embolization device, a second-generation flow diverter for the treatment of intracranial aneurysms, evaluated in an elastase-induced aneurysm model10.1007/s00062-015-0493-9 ↗
55. Safety and efficacy of the derivo Embolization Device for the treatment of unruptured intracranial aneurysms: a multicentric study10.1136/neurintsurg-2018-013963 ↗
56. Age-related complications following endovascular treatment of unruptured intracranial aneurysms10.3174/ajnr.A2881 ↗
57. Very late ischemic complications in flow-diverter stents: a retrospective analysis of a single-center series10.3171/2015.10.JNS15703 ↗
58. Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results10.1136/neurintsurg-2019-015091 ↗
59. Bioresorbable flow diverters for the treatment of intracranial aneurysms: review of current literature and future directions10.1136/neurintsurg-2022-018941 ↗
60. A novel self-expanding primarily bioabsorbable braided flow-diverting stent for aneurysms: initial safety results10.1136/neurintsurg-2019-015555 ↗
61. Early vascular responses to abluminal biodegradable polymer-coated versus circumferential durable polymer-coated newer-generation drug-eluting stents in humans: a pathological study
62. Pathological evaluation of predictors for delayed endothelial coverage after currently available drug-eluting stent implantation in coronary arteries: impact of lesions with acute and chronic coronary syndromes10.1016/j.ahj.2024.08.003 ↗
63. Endothelial recovery in bare metal stents and drug-eluting stents on a single-cell level10.1161/ATVBAHA.121.316472 ↗
64. Promoting endothelialization of flow-diverting stents: a review10.1136/neurintsurg-2020-015874 ↗
65. Evaluation of FeMnN alloy bioresorbable flow diverting stents in the rabbit abdominal aorta
66. Zinc-based alloys for degradable vascular stent applications10.1016/j.actbio.2018.03.005 ↗
67. Design and analysis of a biodegradable polycaprolactone flow diverting stent for brain aneurysms10.3390/bioengineering8110183 ↗
68. Biodegradable flow-diverting device for the treatment of intracranial aneurysm: short-term results of a rabbit experiment10.1007/s00234-013-1150-0 ↗
69. Biodegradable flow diverter for the treatment of intracranial aneurysms: a pilot study using a rabbit aneurysm model10.1161/JAHA.119.014074 ↗
70. Third-generation sirolimus‐eluting bioresorbable tyrocore scaffold implantation in patients with ST‐Segment elevation myocardial infarction: Baseline and 6-Month OCT and clinical Outcomes—A FANTOM STEMI pilot study10.1007/s10557-023-07429-0 ↗
71. 6-Month clinical and angiographic outcomes of a novel radiopaque sirolimus-eluting bioresorbable vascular scaffold: the FANTOM II study10.1016/j.jcin.2017.07.033 ↗
72. Biomechanical challenges to polymeric biodegradable stents10.1007/s10439-015-1477-2 ↗
73. Pipeline flow-diverter stent for treatment of cerebral aneurysms: a single-center experience from Egypt10.1186/s41983-025-01020-0 ↗
74. Benchtop proof of concept and comparison of iron- and magnesium-based bioresorbable flow diverters10.3171/2022.11.JNS222213 ↗
75. Evaluation of FeMnN alloy bioresorbable flow diverters in the rabbit elastase induced aneurysm model10.3389/fbioe.2025.1522696 ↗
76. Evolution of the degradation mechanism of pure zinc stent in the one-year study of rabbit abdominal aorta model10.1016/j.biomaterials.2017.08.022 ↗
77. In-vivo evaluation of molybdenum as bioabsorbable stent candidate
78. The Mo-14Re alloy, a promising candidate material for bioresorbable vascular scaffolds10.1016/j.actbio.2025.08.015 ↗
79. The microstructural evolution and corrosion behavior of Zn-Mg alloys and hybrids processed using high-pressure torsion10.3390/ma17010270 ↗
80. Zinc exhibits ideal physiological corrosion behavior for bioabsorbable stents10.1002/adma.201300226 ↗
81. The influence of alloying and fabrication techniques on the mechanical properties, biodegradability and biocompatibility of zinc: a comprehensive review10.1016/j.actbio.2019.01.035 ↗
82. In vitro degradation behavior and biocompatibility of bioresorbable molybdenum10.3390/met11050761 ↗
83. Thrombogenicity of biodegradable metals
84. Additive manufacturing of biodegradable molybdenum – from powder to vascular stent10.1002/adma.202401614 ↗
85. Ultrafine molybdenum wire braided neurointerventional implants: bridging biodegradability and neurovascular safety for stroke treatment
86. Surface engineering and the application of laser-based processes to stents - a review of the latest development
87. Diffusion-weighted imaging–detected ischemic lesions associated with flow-diverting stents in intracranial aneurysms: safety, potential mechanisms, clinical outcome, and concerns10.3171/2014.10.JNS132566 ↗
88. Gastrointestinal injury caused by aspirin or clopidogrel monotherapy versus dual antiplatelet therapy10.1016/j.jacc.2021.10.027 ↗
89. The crosstalk between endothelial cells, smooth muscle cells, and macrophages in atherosclerosis10.3390/ijms26041457 ↗
90. Vascular smooth muscle cells in atherosclerosis10.1161/CIRCRESAHA.115.306361 ↗
91. Red blood cells in thrombosis10.1182/blood-2017-03-745349 ↗
92. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin10.1182/blood-2013-08-523860 ↗
93. Molecular basis of restenosis and drug-eluting stents10.1161/01.CIR.0000163587.36485.A7 ↗
94. CD31 mimetic coating enhances flow diverting stent integration into the arterial wall promoting aneurysm healing10.1161/STROKEAHA.120.030624 ↗
95. Flow diverter surface modifications for aneurysm treatment: a review of the mechanisms and data behind existing technologies
96. The DERIVO 2 heal embolization device in the treatment of ruptured and unruptured intracranial aneurysms: a retrospective multicenter study10.1007/s00062-024-01446-8 ↗
97. In vitro investigation of an intracranial flow diverter with a fibrin-based, hemostasis mimicking, nanocoating10.1088/1748-605X/abc8d3 ↗
98. Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level10.1016/j.actbio.2013.09.008 ↗
99. Preclinical safety and efficacy evaluation of the pipeline vantage embolization device with shield technology10.1136/neurintsurg-2020-016043 ↗
100. Coating (coating to optimize aneurysm treatment in the new flow diverter generation) study. The first randomized controlled trial evaluating a coated flow diverter (p64 MW HPC): study design10.1136/neurintsurg-2022-018969 ↗